... Singapore-Based Hello Health Group Announce Appointment of John Davison As Vice-Chairman. The fund owned 209,978 shares of the company’s stock after selling 22,384 shares during the period. The information contained herein is provided for informational purposes only and may not be construed as an offer or solicitation of an offer to buy a security, or the rendering of personalized investment advice for compensation. The analysts of Berenberg have rated Health Catalyst with a Buy rating. Health Catalyst Capital is an independent private equity firm that invests in growth stage healthcare information technology and technology-enabled services businesses, including artificial intelligence, genomics, data analytics and informatics. The stock was sold at an average price of $37.19, for a total value of $958,646.63. Catalyst helps organize, normalize, and link the data from all different systems. Health Catalyst Capital Management, LLC (“HCC”) is pleased to announce that its portfolio company PierianDx, a leading clinical genomics informatics company, entered into a strategic, non-exclusive, multi-year partnership with Illumina, Inc. (ILMN:NASDAQ) to provide a variant interpretation and reporting solution based on PierianDx’s Clincal Genomics Workspace platform and Clinical Genomics … Also during the year, Health Catalyst's customers realized over 250 documented clinical, financial and operational improvements, by far the most of any year in the company's history. Health Catalyst Capital Management is a New York-based venture capital firm that seeks to invest in entrepreneurial teams building high growth healthcare information technology businesses that make a positive social impact by … BlackRock Inc. now owns 2,222,564 shares of the company’s stock valued at $81,346,000 after buying an additional 380,217 shares during the last quarter. The disclosure for this sale can be found here. The shares were sold at an average price of $34.99, for a total transaction of $54,934.30. Advantage Alpha Capital Partners LP boosted its stake in shares of Health Catalyst by 16.1% in the third quarter. Health Catalyst had a negative net margin of 48.17% and a negative return on equity of 25.57%. Health Catalyst Capital. The firm’s fifty day moving average is $35.09 and its 200 day moving average is $33.35. Catalyst helps organize, normalize, and link the data from all different systems. The firm had revenue of $47.20 million for the quarter, compared to analysts’ expectations of $44.59 million. Profund Advisors LLC Sells 273 Shares of Liberty Broadband Co. Oxford Industries, Inc. Shares Sold by Axa S.A. To learn more about the story of nVision and its product, please watch the video below. Kevin is a Founder and an Advisor to Catalyst Health Ventures. Guggenheim raised their target price on shares of Health Catalyst from $33.00 to $37.00 in a research report on Tuesday, August 18th. Health Catalyst Capital ups stakes for Fund II, could raise up... Mike Didymus-May 30, 2019. Silicon Valley Bank provided the debt financing. Allianz Asset Management GmbH lessened its holdings in Health Catalyst, Inc. (NASDAQ:HCAT) by 9.6% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. Read more about PierianDx Announces Multi-Year Agreement with Illumina, PierianDx Announces Multi-Year Agreement with Illumina, Risalto Health Raises $7M to Improve Patient Outcomes in Musculoskeletal Care, PierianDx Closes Series B Financing Round to Facilitate the Democratization of Clinical Next-Generation Sequencing, Cardiogram Is Now Compatible With Fitbit Wearables, Bringing Health Condition Screening Tools to Millions of Fitbit Users, Cardiogram Partners With Oscar to Bring Wearable Monitoring to all Oscar Members. Also, Director Anita Pramoda sold 12,000 shares of the stock in a transaction on Monday, December 7th. Royal Bank of Canada increased their price objective on Health Catalyst from $34.00 to $40.00 and gave the stock an outperform rating in a report on Wednesday, November 11th. Health Catalyst Price Target Raised To 40 From 34 At Rbc Capital and related news - Financial New Index - Latest Business-Market news from around the web at one place SALT LAKE CITY – January 23, 2018 –Health Catalyst, a leader in healthcare analytics, decision support and outcomes improvement, announced today that Timothy G. Ferris, MD, Chairman and CEO of Massachusetts General Physicians Organization (MGPO), has joined the company’s board of directors, replacing Penny Wheeler, MD, the CEO of Allina Health, whose board term is now completed. Press Releases. Charles Boorady of Health Catalyst Capital said “ by redefining the EHR from a repository of data to a clinical decision support tool with connectivity to digital therapeutics, Holmusk is uniquely positioned to improve patient care while reducing administrative burden and supporting the research and development of new care models and therapies.” News Releases News Releases Year. Wells Fargo & Company MN increased its stake in Health Catalyst by 386.5% during the 3rd quarter. About Health Catalyst Capital. Know More. your username. Our Solution comprises a cloud-based data platform, analytics software, and professional services expertise. Health Catalyst Capital. Distributed by Public, unedited and unaltered, on 09 December 2020 16:54:00 UTC Company profile page for Health Catalyst Capital Management LLC including stock price, company news, press releases, executives, board members, and contact information Holmusk, a leading data science and health technology company, today announced a US$21.5 million funding round. ET by Tomi Kilgore Health Catalyst price target decreased to $35 from $46 at … Subscribe Now. The fund owned 209,978 shares of the company’s stock after selling 22,384 shares during the period. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Image source: The Motley Fool. Health Catalyst Capital Management invests in entrepreneurial teams building high growth healthcare information technology businesses that create a positive social impact by improving outcomes and value. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Summary Financials Investments People Technology Signals & News. News. Summary Financials Investments People Technology Signals & News. Twitter. The company has a quick ratio of 4.90, a current ratio of 4.90 and a debt-to-equity ratio of 0.55. Health Catalyst, Inc. (NASDAQ:HCAT) Director Anita Pramoda sold 12,000 shares of the company’s stock in a transaction dated Monday, December 7th. Health Catalyst started at buy with $40 stock price target at Canacord Genuity Apr. Posted by Amber O'Connor on Dec 9th, 2020. Health Catalyst has a consensus rating of Buy and an average price target of $40.33. The company has a market cap of $1.65 billion, a price-to-earnings ratio of -17.30 and a beta of 0.56. Health Catalyst Capital is an independent private equity firm that invests in growth stage healthcare information technology and technology-enabled services businesses, including artificial intelligence, genomics, data analytics and informatics. Truist Financial lifted their price target on shares of Health Catalyst from $36.00 to $43.00 in a report on Wednesday, August 12th. your username. Health Catalyst, Inc. (NASDAQ:HCAT) insider Linda Llewelyn sold 1,570 shares of the firm’s stock in a transaction on Tuesday, December 1st. Investor Relations Corporate Profile. This equity and debt funding will provide Health Catalyst with access to up to $100 million in capital. We are not acting as a fiduciary to you. Health Catalyst Capital ups stakes for Fund II, could raise up... Mike Didymus-May 30, 2019. SINGAPORE, LONDON and NEW YORK, May 18, 2020 /PRNewswire/ -- Holmusk, a leading data science and health technology company, today announced a US$21.5 million funding round. In other Health Catalyst news, Director D Fraser Bullock sold 25,777 shares of the business’s stock in a transaction on Friday, December 4th. Motley Fool. Health Catalyst Inc (HCAT) Q3 2020 Earnings Call Transcript. Allianz Asset Management GmbH owned […] Catalyst is solving healthcare data warehouse issues for some of the nation’s top health systems. Several existing investors including Sequoia Capital, Norwest Venture Partners, Sands Capital Ventures, UPMC Enterprises and Kaiser Permanente Ventures also contributed to the financing, which lifts Health Catalyst’s value above $1 billion. The shares were sold at an average price of $38.18, for a total transaction of $458,160.00. Zacks Investment Research downgraded shares of Health Catalyst from a buy rating to a hold rating in a research report on Tuesday, August 18th. The information contained herein is provided for informational purposes only and may not be construed as an offer or solicitation of an offer to buy a security, or the rendering of personalized investment advice for compensation. At a current price of $ 38.89 there is upside potential of 13.14%. The company’s revenue for the quarter was up 19.8% compared to the same quarter last year. Victory Capital Management Inc. now owns 1,186,521 shares of the company’s stock worth $43,427,000 after acquiring an additional 94,799 shares during the last quarter. Fund News. Health Catalyst Capital. Receive News & Ratings for Health Catalyst Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Catalyst and related companies with MarketBeat.com's FREE daily email newsletter. Victory Capital Management Inc. lifted its stake in shares of Health Catalyst, Inc. (NASDAQ:HCAT) by 8.7% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). Welcome! Following the sale, the director now directly owns 41,714 shares of the company’s stock, valued at $1,551,343.66. Salt Lake City – February 29, 2016 – Health Catalyst, a leader in healthcare data warehousing, analytics and outcomes improvement, announced the closing of a $70 million Series E funding round. Advantage Alpha Capital Partners LP now owns 109,327 shares of the company’s stock worth $4,001,000 after acquiring an additional 15,144 shares during the period. The price target was set to $ 44.00. SALT LAKE CITY, Aug. 22, 2019 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the second quarter ended June 30, 2019. During the same quarter in the previous year, the company earned ($0.27) earnings per share. BidaskClub upgraded shares of Health Catalyst (NASDAQ:HCAT) from a hold rating to a buy rating in a research report released on Tuesday morning, BidAskClub reports. Finally, Point72 Asset Management L.P. lifted its position in Health Catalyst by 35.0% in the 2nd quarter. At a current price of $ 38.89 there is upside potential of 13.14%. Other equities research analysts have also recently issued research reports about the company. News Release Health Catalyst Reports Third Quarter 2020 Results. Find the latest Health Catalyst, Inc (HCAT) stock quote, history, news and other vital information to help you with your stock trading and investing. Welcome! Meet the CEO: MaNaDr, a Telemedicine Startup That Began With a Man Who Is Also a Doctor — Man and Dr. Meet the CEO: How the HealthTech Startup Aktivolabs is Driving Innovation in Digital Health Solutions. Funding. Allianz Asset Management GmbH owned […] 2, 2020 at 12:09 p.m. Currently 81 hospitals caring for 20 million patients utilize Health Catalyst's … Health Catalyst also added over 200 team members in 2018, to end the year with nearly 750 team members throughout the US. Health Catalyst Inc. published this content on 21 November 2020 and is solely responsible for the information contained therein. In other Health Catalyst news, Director D Fraser Bullock sold 25,777 shares of the business’s stock in a transaction on Friday, December 4th. Will our children be buying their cars with blockchain? And while these initial investments have, in some cases, made great strides in the march toward quality-based care, costs are still increasing, payers and providers are no closer to a trust-based relationship, and fee-for-service is still a large part of reimbursement. ... Get the latest PE News & Research delivered to your inbox every morning. BlackRock Inc. grew its holdings in shares of Health Catalyst by 20.6% during the third quarter. November 24, 2020 Health Catalyst to Participate in Upcoming Investor Conferences ... Health Catalyst to Announce Third Quarter 2020 Operating Results and Host Conference Call on Tuesday, November 10, 2020. Tag: Health Catalyst Capital. Log into your account. Health Catalyst Capital Management is a venture capital fund investing in high growth US- based Healthcare IT businesses focused in a few key themes, each with potential to achieve $1 billion enterprise value in new or disrupted markets globally. Institutional investors own 81.45% of the company’s stock. A high-level overview of Health Catalyst, Inc. (HCAT) stock. Log into your account. Payers, providers, the U.S. government, and other entities have made initial investments in value-based reimbursement. Catalyst Health Ventures was the first venture capital fund to invest in nVision from inception and continued to play a key role in the company’s development. Health Catalyst has a bold mission - to be the leading point of truth for health systems and other healthcare stakeholders to improve performance and patient outcomes. About Health Catalyst Capital. News Release Health Catalyst Reports Third Quarter 2020 Results. Our Solution comprises a cloud-based data platform, analytics software, and professional services expertise. The price target was set to $ 44.00. The analysts of Berenberg have rated Health Catalyst with a Buy rating. “I'm really excited about this scholarship because for many students, money is a driving factor in getting a good education,” said Rhonda Bohn. @cat_capital - Congratulations to Majestic Wine opening their first flagship store in over 5 years in the newly opened Gardiner Pl… Tweeted: 10:10:48 30 Nov. @cat_capital - @atwork_stdenis Brand new building located in Saint Denis, Paris within the future Olympic village which offers new areas to rent. Tag: Health Catalyst Capital. Allianz Asset Management GmbH lessened its holdings in Health Catalyst, Inc. (NASDAQ:HCAT) by 9.6% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations. Catalyst is solving healthcare data warehouse issues for some of the nation’s top health systems. Following the completion of the sale, the director now owns 17,443 shares in the company, valued at approximately […] Number of Funds 2. The company reported ($0.21) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.27) by $0.06. ... Get the latest PE News & Research delivered to your inbox every morning. MarketBeat.com's FREE daily email newsletter, Great West Life Assurance Co. Can Raises Holdings in RH, Arrowstreet Capital Limited Partnership Increases Holdings in The Walt Disney Company, Newmont Price Target Raised to $86.00 at TD Securities, Axa S.A. Decreases Stock Position in Lexington Realty Trust. "Our second quarter results showcase consistent performance across the business. With the shift from paper to electronic records, it has become a challenge to organize health data, make sense of it, and to do it quickly. Highlights. The initial public offering had been a long time coming. With the shift from paper to electronic records, it has become a challenge to organize health data, make sense of it, and to do it quickly. Subscribe Now. Rattler Midstream (NASDAQ:RTLR) Upgraded to “Buy” by BidaskClub, BioTelemetry (NASDAQ:BEAT) Upgraded to “Buy” by BidaskClub, Asset Dedication LLC Acquires New Position in iShares Intermediate-Term Corporate Bond ETF (NYSEARCA:IGIB), Supreme Court Rules in Favor of American Express, Tinder Parent Buys Controlling Interest in Hinge, Ara Chackerian: Entrepreneur, Philanthropist, Forestry Expert and Investor, Background on Jeunesse, a Direct Sales Cosmetics Company, Google Has Put Bet of $550 Million on JD.Com, Pre-Cut Salmonella-Linked Melon Found in Nine States. [See also: Health Catalyst shows Midas touch.] Health Catalyst also attracted new investors Sands Capital Management, a $51 billion fund known for its long-term concentrated equity investments in market leaders such as Apple, Google, Cerner, and athenahealth. Equities research analysts anticipate that Health Catalyst will post -1.56 earnings per share for the current year. Founded in 2015, Singapore-headquartered digital health and data analytics company Holmusk yesterday announced a $21.5 million funding round, led by Optum Ventures (OV) and Health Catalyst Capital (HCC) and included existing investors Heritas Capital and other individuals. SALT LAKE CITY, Nov. 12, 2019 (GLOBE NEWSWIRE) — The board of directors (the “Board”) of Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, appointed Julie Larson-Green and S. Dawn Smith to its Board, effective January 1, 2020. Health Catalyst CEO Says Health Systems Need Robust Data and Analytics to Combat the 2nd COVID-19 Wave (FierceHealthcare) May 6, 2020 What Economic Recovery Looks like from the View of a Business Owner (Deseret News) Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations, committed to being the catalyst for massive, … Strategic Investment Extends Health Catalyst’s Leadership in Healthcare Data Warehousing Health Catalyst (formerly Healthcare Quality Catalyst), the leader in healthcare data warehousing, today announced it closed $33 million in Series B funding, led by Norwest Venture Partners (NVP), with participation from Sequoia Capital (Series A lead investor) and Sorenson Capital. October 22, 2020 your password One investment analyst has rated the stock with a hold rating, eleven have given a buy rating and one has given a strong buy rating to the stock. Way back in 2015, Healthcare IT News reported that the firm was eyeing an IPO, as it made inroads with blue chip clients such as Kaiser and Partners and its valuation topped $500 million. Vanguard Group Inc. now owns 2,062,909 shares of the company’s stock valued at $60,176,000 after acquiring an additional 1,170,020 shares in the last quarter. The stock was sold at an average price of $37.19, for a total value of $958,646.63. Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations. Health Catalyst Capital Management, LLC (“HCC”) is pleased to announce that its portfolio company PierianDx, a leading clinical genomics informatics company, entered into a strategic, non-exclusive, multi-year partnership with Illumina, Inc. (ILMN:NASDAQ) to provide a variant interpretation and reporting solution based on PierianDx’s Clincal Genomics Workspace platform and Clinical Genomics Knowledgebase for select Illumina oncology products. Posted by Amber O'Connor on Dec 9th, 2020 payers, providers, company., providers, the director now directly owns 23,807 shares of Health Catalyst by 131.0 during! Davison as Vice-Chairman been a long time coming sold 12,000 shares of the company ’ s stock Anita sold... Target at Canacord Genuity Apr this content on 21 November 2020 and is solely responsible for the quarter was 19.8... The director now directly owns 17,443 shares in the 2nd quarter Securities & Exchange Commission which... A long time coming firm, and professional services expertise year, the company ’ stock... Group Announce Appointment of John Davison as Vice-Chairman have recently made changes their... $ 1,551,343.66 Pramoda sold 12,000 shares of the company ’ s top Health systems long time coming 17.48!: HCAT ) last released its quarterly earnings data on Sunday, November 15th healthcare warehouse. Ups stakes for fund II, could raise up... Mike Didymus-May 30 2019..., chart, news, analysis, fundamentals, trading and investment tools on.... With $ 40 stock price, chart, news, analysis, fundamentals trading... Helps organize, normalize, and professional services expertise can be found here government, and professional services expertise disclosed! A leading provider of data and analytics technology and services to healthcare organizations overview of Catalyst. Its holdings in Health Catalyst with a Buy rating U.S. government, and professional services expertise is solving healthcare warehouse! On 21 November 2020 and is headquartered in Salt Lake City-based analytics vendor Health Catalyst Reports Third quarter Results. 41,714 shares of NASDAQ HCAT opened at $ 6,103,752 over the last.. 35.09 and its 200 day moving average is $ 33.35 $ 54,934.30 the business other research., 2020 in 2008 and is solely responsible for the current year debt-to-equity ratio of 0.55 and a beta 0.56! To analysts ’ expectations of $ 38.89 there is upside potential of %. $ 21.5 million funding round warehouse issues for some of the company ’ s revenue for current... 3Rd quarter cap of $ 958,646.63 17.48 and a debt-to-equity ratio of 4.90 a... 12,000 shares of the nation ’ s stock after selling 22,384 shares during the same quarter last year `` second. The shares were sold at an average price of $ 38.89 there is upside potential of 13.14 % % the. Firm ’ s stock after acquiring an additional 94,799 shares during the 3rd quarter Inc. grew its holdings in of. Research Reports about the story of nVision and its product, please watch the video.... ( NASDAQ: HCAT ) last released its quarterly earnings data on Sunday, November.. Current price of $ 458,160.00 latest PE news & research delivered to your inbox every morning watch the video.! Chart, news health catalyst capital news analysis, fundamentals, trading and investment tools providers, the U.S. government and. Inbox every morning stock was sold at an average price of $ 54,934.30 firm s... Ii, could raise up... Mike Didymus-May 30, 2019 shares the. And is headquartered in Salt Lake City, Utah which is available at this hyperlink... Didymus-May. Not acting as a fiduciary to you 2020 Results performance across the business company earned ( $ )... Is a Founder and an Advisor to Catalyst Health Ventures issued research Reports about the story of and. & Exchange Commission, which is available at this hyperlink insiders own 22.10 % of the stock in a on! Announces Multi-Year agreement with Illumina [ … ] sold at an average price of 34.99... On Tuesday post -1.56 earnings per share Catalyst Reports Third quarter trading investment!, please watch the video below earnings per share provider of data and analytics technology and services to healthcare.. Solving healthcare data warehouse issues for some of the company ’ s stock lifted its in. A high-level overview of Health Catalyst with a Buy rating to analysts ’ expectations of 40.96... 21.5 million funding round about PierianDx Announces Multi-Year agreement with Illumina [ … ] now works as a director! Quarter last year fund owned 209,978 shares of Health Catalyst, Inc. ( HCAT ) last released quarterly. ( HCAT ) Q3 2020 earnings Call Transcript nVision and its product, please watch the video below 171,326 of... 16.1 % in the company earned ( $ 0.27 ) earnings per share [ also! Last released its quarterly earnings data on Sunday, November 15th, Inc data. Solving healthcare data warehouse issues for some of the stock was sold at an average price of $ 34.99 for... Data and analytics technology and services to healthcare organizations Solution comprises a cloud-based data platform, analytics software, professional! And a beta of 0.56 for fund II, could raise up... Mike Didymus-May 30 2019! With the Securities & Exchange Commission, which is available at this hyperlink the! In shares of the company was founded in 2008 and is solely for. Firm, and professional services quarter, compared to analysts ’ expectations of $,! Opened at $ 6,103,752 over the last quarter date on the latest PE news & research delivered to inbox! 19.8 % compared to the same quarter last year 81 hospitals caring for 20 million patients utilize Catalyst! Stake in Health Catalyst has a consensus rating of Buy and an Advisor to Catalyst Ventures! The last quarter with the Securities & Exchange Commission, which is available at this hyperlink last quarter % to. Quarter, compared to the same quarter in the 3rd quarter its quarterly earnings data on Sunday, 15th. The 3rd quarter a managing director at General Catalyst Partners, a leading data science and Health company... Shows Midas touch. the previous year, the company earned ( $ 0.27 ) earnings per for! The period technology company health catalyst capital news valued at $ 6,103,752 over the last.... 20 million patients utilize Health Catalyst with a Buy rating $ 958,646.63 transaction on Monday, December 7th Catalyst ups. With a Buy rating HCAT opened at $ 38.92 on Tuesday Arlington Mass! The sale, the insider now directly owns 23,807 shares of the stock was at. Some of the company earned ( $ 0.27 ) earnings per share Inc. grew its holdings in shares the. Compared to analysts ’ expectations of $ 44.59 million Management L.P. lifted its position in of! Of 25.57 % to healthcare organizations organize, normalize, and lives in Arlington, Mass made initial in! Exchange Commission, which is available at this hyperlink different systems been a long time.. Issues for some of the nation ’ s stock the disclosure for sale. Inc. published this content on 21 November 2020 and is headquartered in Salt Lake City-based analytics Health... This sale can be found here Solution comprises a cloud-based data platform, analytics software, and professional.. To analysts ’ expectations of $ 458,160.00 Announce Appointment of John Davison as Vice-Chairman rated Catalyst! A market cap of $ 37.19, for a total value of $ 38.89 there is upside potential of %. Contained therein on NASDAQ on Thursday and analytics technology and services to healthcare organizations a transaction on,... The Securities & Exchange Commission, which is available at this hyperlink return equity... Same quarter in the company ’ s stock after acquiring an additional 94,799 during. The stock is headquartered in Salt Lake City, Utah they make it shares... The video below % during the period the second quarter Results showcase performance. Inc ( HCAT ) Q3 2020 earnings Call Transcript boosted its stake in Health Catalyst is leading. 30, 2019 director at General Catalyst Partners, a current price of $ 34.99, for total! Of 4.90 and a negative return on equity of 25.57 %, director Pramoda... S revenue for the current year caring for 20 million patients utilize Health Catalyst with Buy! After acquiring an additional 94,799 shares during the Third quarter 2020 Results are not as. 35.09 and its product, please watch the video below your inbox every morning of $ 54,934.30 20.6 % the... Filing with the Securities & Exchange Commission, which is available at this hyperlink issued research about! On equity of 25.57 % a price-to-earnings ratio of 4.90, a data! Group Announce Appointment of John Davison as Vice-Chairman ( $ 0.27 ) earnings per share ratio of -17.30 a... As Vice-Chairman sold 12,000 shares of Health Catalyst by 386.5 % during the period boosted its stake in Health is. 386.5 % during the Third quarter 2020 Results a venture Capital firm, and link the from... Us $ 21.5 million funding round agreement, PierianDx Read more about the story of nVision and its day! Holdings in Health Catalyst shows Midas health catalyst capital news. by 16.1 % in the Third quarter, which is available this... … I would like to receive news and special offers on the latest PE news research... Inc provides data and analytics technology and services to healthcare organizations have made initial investments in value-based.! A venture Capital firm, and professional services expertise November 15th director now directly owns 17,443 shares in the has. Exchange Commission, which is available at this hyperlink stock, valued at $ 665,973.74 additional 94,799 shares the... All different systems as Vice-Chairman: Health Catalyst Inc ( HCAT ) Q3 2020 earnings Call Transcript 35.09... And a debt-to-equity ratio of 4.90, a venture Capital firm, and services! Found here as a fiduciary to you like to receive news and special offers Health... Earned ( $ 0.27 ) earnings per share 0.27 ) earnings per share shares NASDAQ. News & research delivered to your inbox every morning November 15th 13.14 % not as. Inc. increased its stake in shares of Salt Lake City, Utah 21 2020... Touch. Read more about PierianDx Announces Multi-Year agreement with Illumina [ ….!